EUVIMEDEUVIMED entdecken
Crossref

TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis

Fangyu Hu, Lingling Zhao, Junyu Wang, Xiaoying Li, Zixuan Xue, Yimeng Ma, Minghui Zheng, Chenglin Chen, Meiting Tong, Xiaohuan Guo, Hongyan Li, Honglei Jin und 4 weitere

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2024

DOI: 10.1016/j.bbamcr.2024.119855 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024. Verfasst von Fangyu Hu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine a…. Hauptthemen laut MEDLINE: Cell Proliferation, Colorectal Neoplasms, Cyclin-Dependent Kinase Inhibitor p21, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province, Key Discipline of Zhejiang Province in Medical Technology, New York University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer (CRC) is the most common malignancy of the digestive tract, and to date, morbidity and mortality rates remain high. While existing therapeutic methods have achieved certain effective outcomes, there are still many problems in treating this disease. Therefore, it is still urgent to constantly find new therapeutic targets in CRC that could lead to new therapeutics. METHODS: Immunohistochemistry, Real-time PCR and Western Blot were employed to measure mRNA and protein levels of the target protein, respectively. The proliferation ability of CRC cells was evaluated using ATP assay, Soft agar assay, and nude mouse subcutaneous tumorigenesis assay. Protein Degradation Assay was conducted to determine protein degradation rate, while Ubiquitination assay was used to assess the ubiquitination modification level of target proteins. Immunoprecipitation assay was used to study protein interactions, and pull-down assay was employed to investigate direct interactions between proteins. RESULTS: TRIM40 was significantly down-regulated in CRC tissues, with its expression levels positively correlating with disease prognosis. Using both in vitro and in vivo approaches, it was demonstrated that TRIM40 could significantly inhibit the proliferation of CRC cells. Molecular mechanism studies showed that TRIM40 directly binds to and ubiquitinates ROCK1 protein, accelerating its degradation and subsequently reducing the stability of c-Myc protein. This cascade of events results in the release of transcriptional inhibition of p21 by c-Myc, leading to increased p21 expression and G0/G1 phase arrest in CRC cells. CONCLUSION: This research suggests that TRIM40 could be a valuable therapeutic target for the treatment of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationColorectal NeoplasmsCyclin-Dependent Kinase Inhibitor p21Proto-Oncogene Proteins c-mycrho-Associated KinasesAnimalsFemaleHumansMaleMiceCell Line, TumorGene Expression Regulation, NeoplasticHCT116 CellsMice, NudeSignal TransductionTripartite Motif ProteinsUbiquitin-Protein LigasesUbiquitination

Stichwörter der Autor:innen

CRCCell cycleROCK1TRIM40Ubiquitination

Substanzen

CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21MYC protein, humanProto-Oncogene Proteins c-mycrho-Associated KinasesTripartite Motif ProteinsUbiquitin-Protein LigasesROCK1 protein, humanTRIM40 protein, human

Autor:innen und Institutionen

  • Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035…
  • Department of Laboratory Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Förderung

  • Science and Technology Department of Zhejiang Province
  • Key Discipline of Zhejiang Province in Medical Technology
  • New York University

Zitieren

APA

Hu, F., Zhao, L., Wang, J., Li, X., Xue, Z., Ma, Y., Zheng, M., Chen, C., Tong, M., Guo, X., Li, H., Jin, H., Xie, Q., Zhang, X., Huang, C., & Huang, H. (2024). TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2024.119855

Vancouver

Hu F, Zhao L, Wang J, Li X, Xue Z, Ma Y, et al. TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2024. doi:10.1016/j.bbamcr.2024.119855

BibTeX
@article{Hu2024,
  author = {Hu, Fangyu and Zhao, Lingling and Wang, Junyu and Li, Xiaoying and Xue, Zixuan and Ma, Yimeng and Zheng, Minghui and Chen, Chenglin and Tong, Meiting and Guo, Xiaohuan and Li, Hongyan and Jin, Honglei and Xie, Qipeng and Zhang, Xiaodong and Huang, Chuanshu and Huang, Haishan},
  title = {TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Cell Research},
  year = {2024},
  doi = {10.1016/j.bbamcr.2024.119855}
}
Kostenlos starten →